Pharma

Tiny green sprout growing from soil
Biotech

Chiesi fertilizes Arbor's gene therapy with $2B biobucks deal

Chiesi is shelling out $115 million upfront to develop and commercialize ABO-101, a gene therapy for primary hyperoxaluria type 1.
Darren Incorvaia Oct 6, 2025 7:00am
helicopter rescue mission save aircraft

Ignota buys Kronos' pipeline to rescue shelved programs

Oct 6, 2025 5:45am
flu immune system virus influenza COVID infection
Favicon Fierce Pharma

Cidara snares BARDA award to boost R&D, production of flu asset

Oct 3, 2025 10:10am
three triple doors opportunity cracked open ajar

89bio was left between a Roche and a hard place in buyout talks

Oct 2, 2025 9:55am
Novo

Novo vs. KBP Chapter 2: 'Anomalous' trial results

Oct 2, 2025 3:00am
puzzle pieces merger and acquisition business concept
Favicon Fierce Pharma

Halozyme buys Elektrofi for up to $900M

Oct 1, 2025 2:36pm